- Home
- LQDT vs NUVB Comparison
LQDT vs NUVB Comparison
Compare LQDT & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LQDT
- NUVB
- Stock Information
- Founded
- LQDT 1999
- NUVB 2018
- Country
- LQDT United States
- NUVB United States
- Employees
- LQDT N/A
- NUVB N/A
- Industry
- LQDT Catalog/Specialty Distribution
- NUVB Biotechnology: Pharmaceutical Preparations
- Sector
- LQDT Consumer Discretionary
- NUVB Health Care
- Exchange
- LQDT Nasdaq
- NUVB Nasdaq
- Market Cap
- LQDT 805.9M
- NUVB 837.0M
- IPO Year
- LQDT 2006
- NUVB N/A
- Fundamental
- Price
- LQDT $26.77
- NUVB $3.89
- Analyst Decision
- LQDT Strong Buy
- NUVB Strong Buy
- Analyst Count
- LQDT 2
- NUVB 6
- Target Price
- LQDT $38.50
- NUVB $8.00
- AVG Volume (30 Days)
- LQDT 275.4K
- NUVB 6.2M
- Earning Date
- LQDT 08-07-2025
- NUVB 11-05-2025
- Dividend Yield
- LQDT N/A
- NUVB N/A
- EPS Growth
- LQDT 33.77
- NUVB N/A
- EPS
- LQDT 0.83
- NUVB N/A
- Revenue
- LQDT $465,508,000.00
- NUVB $14,355,000.00
- Revenue This Year
- LQDT $31.57
- NUVB $332.80
- Revenue Next Year
- LQDT $2.58
- NUVB $360.12
- P/E Ratio
- LQDT $32.25
- NUVB N/A
- Revenue Growth
- LQDT 38.40
- NUVB 900.35
- 52 Week Low
- LQDT $21.02
- NUVB $1.54
- 52 Week High
- LQDT $39.72
- NUVB $4.09
- Technical
- Relative Strength Index (RSI)
- LQDT 59.15
- NUVB 83.37
- Support Level
- LQDT $25.80
- NUVB $2.87
- Resistance Level
- LQDT $26.63
- NUVB $3.08
- Average True Range (ATR)
- LQDT 0.66
- NUVB 0.22
- MACD
- LQDT 0.03
- NUVB 0.08
- Stochastic Oscillator
- LQDT 67.23
- NUVB 86.52
About LQDT Liquidity Services Inc.
Liquidity Services Inc is an online auction marketplace. It manages and sells inventory and equipment for business and government clients by operating a network of e-commerce marketplaces that enable buyers and sellers to transact in an efficient, automated environment offering across different product categories. The company has four reportable segments: GovDeals, Capital Assets Group (CAG), Retail Supply Chain Group (RSCG), and Machinio. It generates majority of its revenue from Retail Supply Chain Group (RSCG) segment which consists of marketplaces that enable corporations located in the United States and Canada to sell excess, returned, and overstocked consumer goods. Geographically, a substantial portion the company's revenue is generated from its business in United States.
About NUVB Nuvation Bio Inc.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.